✦ LIBER ✦

Anemia management in chronic kidney disease: Intravenous iron steps forward

✍ Scribed by Daniel W. Coyne; Michael Auerbach

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 77 KB
Volume: 85
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.21682

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of anemia in chronic kidney d

Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study

✍ Tadao Akizawa; Hirofumi Makino; Seiichi Matsuo; Tsuyoshi Watanabe; Enyu Imai; Ko 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 435 KB

Intravenous iron treatment in paediatric

Intravenous iron treatment in paediatric chronic kidney disease patients not on erythropoietin

✍ Henry E. G. Morgan; Richard C. L. Holt; Caroline A. Jones; Brian A. Judd 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 74 KB

FDA report: Ferumoxytol for intravenous

FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Feraheme™ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise

Iron deficiency in patients with chronic

Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin

✍ James B. Post; Barry M. Wilkes; Michael F. Michelis 📂 Article 📅 2006 🏛 Springer Netherlands 🌐 English ⚖ 157 KB